Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
Molecular Effects of Topical Calcipotriene on Morphea
Genetic Variants in Linear Localized Scleroderma
Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma
Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea
Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
Imiquimod in Children With Plaque Morphea
Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea
|10||Active, not recruiting||
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
The CARRA Registry
UVA1 Light for Scleroderma and Similar Conditions
UVA1 Light for Treatment of Scleroderma and Similar Conditions
Microvascular and Fibrosis Imaging Study
† Study has passed its completion date and status has not been verified in more than two years.